Australian Clinical Labs Limited (ASX: ACL)
Australia
· Delayed Price · Currency is AUD 3.450
+0.100 (2.99%)
Jan 21, 2025, 4:10 PM AEST
Australian Clinical Labs Market Cap
Australian Clinical Labs has a market cap or net worth of 686.49 million as of January 17, 2025. Its market cap has increased by 17.66% in one year.
Market Cap
686.49M
Enterprise Value
968.78M
Revenue
696.37M
Ranking
n/a
PE Ratio
28.75
Stock Price
3.45
Market Cap Chart
Since May 14, 2021, Australian Clinical Labs's market cap has decreased from 690.27M to 686.49M, a decrease of -0.55%. That is a compound annual growth rate of -0.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2025 | 666.59M | -2.62% |
| Dec 31, 2024 | 684.50M | 18.13% |
| Dec 29, 2023 | 579.45M | -3.17% |
| Dec 30, 2022 | 598.41M | -52.18% |
| Dec 31, 2021 | 1.25B | 81.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 132.95B |
| Pro Medicus | 26.99B |
| Cochlear | 20.21B |
| Sonic Healthcare | 13.38B |
| Telix Pharmaceuticals | 8.74B |
| Ramsay Health Care | 7.71B |
| Ansell | 4.99B |
| Sigma Healthcare | 4.48B |